Researchers have made advancements in immune systems for children, potentially allowing for more adventurous childhoods. A newly FDA-approved therapy may be responsible for these developments. The breakthrough appears to be related to a decade of gene therapy research, possibly connected to studies on sickle cell disease at institutions such as UCLA.